X

XenTech

30 employees

XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
efficacy preclinical studies
Health Care
PDX
biomarkers
CDX
in-vitro assays
in vivo
oncology
patient-derived tumor xenograft models
Life Science

Date founded

2006

Funding rounds raised

Total raised

$765K

from 1 investors over 1 rounds

X

XenTech raised $765K on October 31, 2008

Investors: Aurinvest Capital 3

FAQ